Hope for Small Cell Lung Cancer Patients

Small Cell Lung Cancer news: The combination of nivolumab plus ipilimumab led to durable responses in previously treated patients with small cell lung cancer, according to results from the CheckMate 032 trial presented at the 2017 ASCO Annual Meeting.

“Unfortunately, outcomes and treatment options for patients with recurrent small cell lung cancer are poor,” Matthew David Hellmann, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, said during his presentation. “New breakthroughs in the space are critically needed.”

Learn more

More Lung Cancer Research News: